Cód QR

Quality of life in patients with pulmonary embolism treated with edoxaban versus warfarin

Abstract Background Long‐term sequelae of acute pulmonary embolism (PE) include decreased quality of life (QoL). Evidence suggests that adequacy of initial anticoagulant treatment in the acute phase of venous thrombosis has a key impact on late postthrombotic complications. We hypothesize that patie...

Cur síos iomlán

Sábháilte in:
Príomhchruthaitheoirí: Roisin Bavalia, Ingrid M. Bistervels, Wim G. Boersma, Isabelle Quere, Dominique Brisot, Nicolas Falvo, Dominique Stephan, Francis Couturaud, Sebastian Schellong, Jan Beyer‐Westendorf, Karine Montaclair, Waleed Ghanima, Marije ten Wolde, Michiel Coppens, Emile Ferrari, Olivier Sanchez, Patrick Carroll, Pierre‐Marie Roy, Susan R. Kahn, Karina Meijer, Simone Birocchi, Michael J. Kovacs, Amanda Hugman, Hugo ten Cate, Hilde Wik, Gilles Pernod, Marie‐Antoinette Sevestre‐Pietri, Michael A. Grosso, Minggao Shi, Yong Lin, Barbara A. Hutten, Peter Verhamme, Saskia Middeldorp, the Hokusai post‐PE study investigators
Formáid: Artigo
Teanga:Inglês
Foilsithe / Cruthaithe: Elsevier 2021-07-01
Sraith:Research and Practice in Thrombosis and Haemostasis
Ábhair:
edoxaban
pulmonary embolism
quality of life
warfarin
Rochtain ar líne:https://doi.org/10.1002/rth2.12566
Clibeanna: Cuir clib leis
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!

Míreanna comhchosúla